English
Home > Products > Ranolazine advance intermediate

China Ranolazine advance intermediate Factory

Reliable top quality and great credit score standing are our principles, which will help us at a top-ranking position. Adhering on the tenet of "quality first, consumer supreme" for Ranolazine advance intermediate,CAS NO 2210-74-4,2210-74-4,Ranolazine intermediate,Guaiacol glycidyl ether, Sincerely stay up for serving you from the in the vicinity of future. You are sincerely welcome to go to our company to talk company face to face with each other and create long-term co-operation with us!
Ranolazine advance intermediate, we've been sincerely hope to establish one good long term business relationship with your esteemed company thought this opportunity, based on equal, mutual beneficial and win win business from now till the future.

Related Products

Hot Products

  • Pantoprazole

    Pantoprazole

    Product Name:Pantoprazole
    Molecular Formula:C16H15F2N3O4S
    Molecular Weight;383.37
    CAS Registry Number;102625-70-7
  • 1-Isopropyl-1H-pyrazole-5-boronic acid, pinacol ester

    1-Isopropyl-1H-pyrazole-5-boronic acid, pinacol ester

    Product Name:1-Isopropyl-1H-pyrazole-5-boronic acid, pinacol ester
    Molecular Formula:C12H21BN2O2
    Molecular Weight:236.12
    CAS Registry Number:1282518-60-8
  • (2R,3S)-3-(tert-Butoxycarbonyl)amino-1,2-epoxy-4-phenylbutane

    (2R,3S)-3-(tert-Butoxycarbonyl)amino-1,2-epoxy-4-phenylbutane

    Product Name:(2R,3S)-3-(tert-Butoxycarbonyl)amino-1,2-epoxy-4-phenylbutane
    Molecular Formula:C15H21NO3
    Molecular Weight:263.34
    CAS Registry Number:98760-08-8
  • Synephrine

    Synephrine

    Product Name:Synephrine
    Molecular Formula:C9H13NO2
    Molecular Weight:167.21
    CAS Registry Number:94-07-5
  • Oclacitinib maleate

    Oclacitinib maleate

    Product Name:Oclacitinib maleate
    Molecular Formula:C19H27N5O6S
    Molecular Weight;453.51258
    CAS Registry Number;1640292-55-2
  • Potassium sulfate

    Potassium sulfate

    Product Name:Potassium sulfate
    Molecular Formula:K2O4S
    Molecular Weight:174.2592
    CAS Registry Number;13647-35-3
  • Related Blog
  • Reviews

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products...

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept